Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL9561601 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL4368937 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL29639883 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL7521652 | 0.94 | SLC34A1 (0.39) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL9169816 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL10758464 | 0.94 | SLC34A1 (0.39) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL6835712 | 0.94 | SLC34A1 (0.39) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL28257 | 0.94 | SLC34A1 (0.46) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL32680448 | 0.89 | — | — | |
| Phosphoric Acid SCHEMBL28234077 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119612842-A | System and method for cooperatively treating cultivation manure, farmland water return and processing waste | 山东师范大学 | 2025-03-14 | — | — | CN | claimed |
| CN-114133117-B | Full-volume treatment system and treatment method for sludge dewatering supernatant | 天津高能时代水处理科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118405799-A | Wastewater treatment system with energy-saving and carbon-reducing functions and treatment method | 云南碳合环境科技有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-111847644-B | Method and device for recycling low-concentration phosphorus in sewage by utilizing sequencing batch aerobic granular sludge reactor | 江苏美景时代环保科技有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-109467225-B | Wastewater treatment reactor and treatment method | 济南嘉能可环境工程有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-220449904-U | Industrial wastewater crystallization treatment device | 云南磷源化工有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-114249361-A | Standard treatment system and method suitable for high-ammonia-nitrogen high-magnesium desulfurization wastewater | 华能山东发电有限公司白杨河发电厂 | 2022-03-29 | — | — | CN | claimed |
| US-20130068695-A1 | Methods and Compositions For the Prevention of Struvite Scale Formation In Wastewater Systems | PREMIER MAGNESIA, LLC | 2013-03-21 | — | — | US | claimed |
| EP-1910581-B1 | PROCESS FOR METALS RECOVERY FROM SPENT CATALYST | CHEVRON USA INC (US) | 2011-09-07 | — | — | EP | claimed |
| US-7736607-B2 | Process for metals recovery from spent catalyst | CHEVRON U.S.A. INC (US) | 2010-06-15 | — | — | US | claimed |
| US-7528278-B2 | Transesterification process for production of (meth)acrylate ester monomers | ROHM AND HAAS COMPANY (US) | 2009-05-05 | — | — | US | claimed |
| US-20090110620-A1 | PROCESS FOR METALS RECOVERY FROM SPENT CATALYST | MARCANTONIO PAUL J | 2009-04-30 | — | — | US | claimed |
| US-7485267-B2 | Process for metals recovery from spent catalyst | CHEVRON U.S.A. INC. (US) | 2009-02-03 | — | — | US | claimed |
| EP-1910581-A2 | PROCESS FOR METALS RECOVERY FROM SPENT CATALYST | Chevron U.S.A., Inc. (US) | 2008-04-16 | — | — | EP | claimed |
| EP-1867637-A2 | Transesterification process for production of (meth)acrylate ester monomers | Rohm and Haas Company (US) | 2007-12-19 | — | — | EP | claimed |
| US-20070287841-A1 | Transesterification process for production of (meth)acrylate ester monomers | ROHM AND HAAS COMPANY | 2007-12-13 | — | — | US | claimed |
| WO-2007018805-A2 | PROCESS FOR METALS RECOVERY FROM SPENT CATALYST | CHEVRON U.S.A. INC. (US) | 2007-02-15 | — | — | WO | claimed |
| US-20070025899-A1 | Recovering V, Ni and Mo from spent, unsupported hydroprocessing catalyst by leaching in H2O with oxidizer; filtration to produce NH4VO3 & crystallizing and calcining to produce V2O5 which is removed; scrubbing and stripping organic phase to remove NiSO4; extraction or precipitation to remove Mo compounds | CHEVRON U.S.A. INC. | 2007-02-01 | — | — | US | claimed |
| US-20020114753-A1 | Magnesium ammonium phosphate hexahydrate and monohydrate slurries | PHILIP MORRIS USA INC. | 2002-08-22 | — | — | US | claimed |
| WO-2002014218-A1 | MAGNESIUM AMMONIUM PHOSPHATE HEXAHYDRATE AND MONOHYDRATE SLURRIES | GREEN, J., RICHARD (US) | 2002-02-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287841-A1 | Transesterification process for production of (meth)acrylate ester monomers | METTL14, MMAB, TET1 | SLC34A1 853/4885LMNA 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.